前列腺癌：高危疾病中辅助化疗无证据支持。 - Suppr

Suppr

超能文献

Prostate cancer: No evidence for adjuvant chemotherapy in high-risk disease.

作者信息

Albers Peter

机构信息

Department of Urology, University Hospital Duesseldorf, Moorenstrasse 5, D-40225 Duesseldorf, Germany.

出版信息

Nat Rev Urol. 2015 Nov;12(11):602-3. doi: 10.1038/nrurol.2015.219. Epub 2015 Sep 1.

DOI:10.1038/nrurol.2015.219

PMID:26334083

Abstract

摘要

相似文献

Prostate cancer: No evidence for adjuvant chemotherapy in high-risk disease.

Nat Rev Urol. 2015 Nov;12(11):602-3. doi: 10.1038/nrurol.2015.219. Epub 2015 Sep 1.

Role for androgen withdrawal prior to radiation and surgery for prostate cancer?

Oncology (Williston Park). 1997 May;11(5):738.

[Diagnosis and treatment of early prostate cancer].

Vopr Onkol. 2009;55(3):382-5.

Role of radiation and androgen deprivation therapy for advanced prostate cancer.

Curr Probl Cancer. 2015 Jan-Feb;39(1):41-7. doi: 10.1016/j.currproblcancer.2014.11.007. Epub 2014 Nov 25.

Ageism in the undertreatment of high-risk prostate cancer: how long will clinical practice patterns resist the weight of evidence?

J Clin Oncol. 2015 Mar 1;33(7):676-8. doi: 10.1200/JCO.2014.59.4093. Epub 2015 Jan 5.

Androgen suppression plus radiation for prostate cancer.

JAMA. 2004 Dec 1;292(21):2581-2; author reply 2582. doi: 10.1001/jama.292.21.2581-b.

Adjuvant medical therapy for prostate cancer.

Expert Opin Pharmacother. 2011 Jan;12(1):73-84. doi: 10.1517/14656566.2010.516252. Epub 2010 Dec 1.

Treatment of prostate cancer with hormonal therapy in Europe.

BJU Int. 2009 Mar;103 Suppl 2:2-6. doi: 10.1111/j.1464-410X.2009.08382.x.

Radiation therapy and androgen suppression as treatment for clinically localized prostate cancer: the new standard?

JAMA. 2004 Aug 18;292(7):864-6. doi: 10.1001/jama.292.7.864.

Carcinoma of the prostate: neoadjuvant hormonotherapy followed by radiotherapy.

Acta Urol Belg. 1996 May;64(2):63-4.

本文引用的文献

A Phase 3 Trial of 2 Years of Androgen Suppression and Radiation Therapy With or Without Adjuvant Chemotherapy for High-Risk Prostate Cancer: Final Results of Radiation Therapy Oncology Group Phase 3 Randomized Trial NRG Oncology RTOG 9902.

Int J Radiat Oncol Biol Phys. 2015 Oct 1;93(2):294-302. doi: 10.1016/j.ijrobp.2015.05.024. Epub 2015 Jul 21.

Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911).

Lancet. 2012 Dec 8;380(9858):2018-27. doi: 10.1016/S0140-6736(12)61253-7. Epub 2012 Oct 19.

Phase III multi-institutional trial of adjuvant chemotherapy with paclitaxel, estramustine, and oral etoposide combined with long-term androgen suppression therapy and radiotherapy versus long-term androgen suppression plus radiotherapy alone for high-risk prostate cancer: preliminary toxicity analysis of RTOG 99-02.

Int J Radiat Oncol Biol Phys. 2009 Mar 1;73(3):672-8. doi: 10.1016/j.ijrobp.2008.05.020. Epub 2008 Nov 5.

Androgen suppression plus radiation versus radiation alone for patients with stage D1/pathologic node-positive adenocarcinoma of the prostate: updated results based on national prospective randomized trial Radiation Therapy Oncology Group 85-31.

J Clin Oncol. 2005 Feb 1;23(4):800-7. doi: 10.1200/JCO.2005.08.141.

Cancer-specific mortality after surgery or radiation for patients with clinically localized prostate cancer managed during the prostate-specific antigen era.

J Clin Oncol. 2003 Jun 1;21(11):2163-72. doi: 10.1200/JCO.2003.01.075.

Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial.

Lancet. 2002 Jul 13;360(9327):103-6. doi: 10.1016/s0140-6736(02)09408-4.

Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer.

JAMA. 1998 Sep 16;280(11):975-80. doi: 10.1001/jama.280.11.975.

Is there evidence that chemotherapy is of benefit to patients with carcinoma of the prostate?

J Clin Oncol. 1985 Jul;3(7):1013-21. doi: 10.1200/JCO.1985.3.7.1013.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验